Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in 2005 by acquiring CP Medical, Inc., and have continued to expand with the acquisitions of Galt Medical Corp., NeedleTech Products, Inc., Concert Medical, and Arrotek.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.